I n this issue of Arteriosclerosis, Thrombosis, and Vascular Biology, Shimoyama et al 1 demonstrates that neointimal formation after vascular injury is enhanced in CCN3 knockout mice, suggesting that CCN3 suppresses neointimal thickening. In addition, the results from in vitro approaches further demonstrate that CCN3 inhibits vascular smooth muscle cell (VSMC) growth and migration, and the inhibitory effect of CCN3 on VSMC growth is mediated in part by the activation of Notch signaling. The inhibitory effect of CCN3-Notch signaling on VSMC proliferation is interesting; however, it appears opposite or contradictory to most previous reports of Notch signaling in VSMC (Figure) . The activation of Notch receptor results from 2 types of proteolytic cleavages by ADAM10 (or TACE) metalloprotease and ␥-secretase complex, which release Notch intracellular domain from the cell membrane. The Notch intracellular domain enters the nucleus and interacts with DNA-binding protein recombination signal-binding protein for immunoglobulin kappa J region, leading to the transcriptional activation of Notch target gene, including Hes and Hey. 2, 3 Sakata et al 4 have reported that neointimal formation was significantly reduced in Hey2 Ϫ/Ϫ mice. It has also been reported that both Hey1 and Hey2 overexpression in VSMC increased cell proliferation by reducing p21waf1 or p27kip1 expression. 5 In addition, a recent study further showed that the neointimal formation after carotid artery ligation was decreased 70% in systemic Notch 1 heterozygous-deficient (N1 ϩ/Ϫ ) mice or VSMCspecific Notch 1 heterozygous-deficient (smN1 ϩ/Ϫ ) mice compared with wild-type control mice. Smooth muscle cells derived from N1 ϩ/Ϫ or smN1 ϩ/Ϫ mice had decreased proliferation and increased apoptosis compared with wild-type controls. 6 These results indicate that the activation of Notch 1 in VSMC promotes VSMC proliferation and neointimal formation after vascular injury and suggests a "proproliferation" role of Notch-Hey signaling in VSMC.
See accompanying article on page 675
In contrast, the current study shows that CCN3 increased the expression of both p21 and Hey1 (a downstream gene targeted by the Notch signaling) in cultured VSMC. GSI (a ␥-secretase inhibitor) partially inhibited CCN3-induced p21 expression and VSMC proliferation. RPMS-1 (a known blocker of recombination signal binding protein for immunoglobulin kappa J region-mediated Notch signaling pathway) also inhibited CCN3-mediated increase of p21 and Hey1. These data support that the activation of Notch signaling at least in part contributes to the inhibitory effect of CCN3 on VSMC proliferation, probably via increase of p21 and Hey1. Thus, the current study suggests an antiproliferating effect of Notch signaling in VSMC in the presence of CCN3. The contradictory role of Notch signaling in VSMC proliferation could be attributable to the fact that the Notch signaling activated by canonical Notch ligands is somewhat different from the Notch signaling stimulated via noncanonical ligands such as CCN3. It has been appreciated that different Notch ligands could induce distinct signaling responses and biological effects. 7 In addition, CCN3 itself appears to be a contradictory molecule in cell proliferation. 8 It has been proposed that nuclear accumulation and transcriptional regulation under different conditions may be critical for CCN3 to decide its effects as proproliferation or antiproliferation. 9 Moreover, the expression of cell cycle modulator p21 can be regulated by variety of signaling molecules and transcription factors, such as p53, 10,11 KLF2, 12 SP1, 13 and TCF3. 14 It is possible that the effect of Notch signaling on p21 expression may vary in response to different agonists or upstream regulators. Nevertheless, the precise role of Notch signaling in mediating CCN3 inhibitory effects on VSMC proliferation and neointimal formation deserves to be further evaluated in the context of several Notch signaling-deficient mice and cells. Besides Notch signaling, the role and mechanism of CCN3 on VSMC proliferation also needs to be further investigated in other signaling pathways that may be coordinately involved in the regulation of cell-cycle protein expression by CCN3.
This article accompanies the DVT Series that was published in the March 2010 issue.
The importance of CCN family has been reported in the process of angiogenesis, proliferation, tumorigenesis, wound healing, adhesion, and survival. [15] [16] [17] The CCN family contains 6 members designated CCN1 through CCN6. Detection of CCN expression under various pathological conditions suggests that these isoforms have critical but different functions. [15] [16] [17] In the regulation of cell proliferation, CCN1 and CCN3 seem to play different roles, although CCN1 and CCN3 share similar primary structure and domain organization. For example, Matsumae et al 18 have reported that knockdown of CCN1 expression using lentiviral vector expressing CCN1 siRNA significantly inhibited neointimal formation in rat balloon-injured carotid arteries. CCN1 stim-ulated VSMC proliferation through the interaction with integrin, such as ␣v␤3 and a6b1. 17 Furthermore, CCN1-integrin association causes sustained ERK1/2 activation and induces cell proliferation. 19 However, CCN3 can associate not only with integrins but also with Notch 1, 20 Fubulin1c, 21 and BMP-2, 22 which may explain the different responses of neointimal formation observed between CCN1 and CCN3. 18 The characteristics of multiple binding partners of CCN3 may also suggest that CCN3-stimulated Notch signaling could be modulated by other signaling molecules associating with CCN3, which leads to a biological response distinct from other ligand-stimulated Notch signaling. The roles of other CCN members in VSMC proliferation remain unknown; therefore, further investigation is needed. This will provide insight into the confounding but complicated roles of CCN, integrins, and Notch signaling in VSMC biology.
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